Upper-airway Changes After Bimaxillary Advancement in OSAHS
OSAHS
1 other identifier
observational
38
1 country
1
Brief Summary
One of the most effective surgical treatments for obstructive sleep apnoea / hypopnoea syndrome (SAHS) with global impact on the upper-airway (UA) is the maxilla-mandibular advancement (MMA). Retrospective-prospective observational study of: clinical outcomes, UA and dental-cranium-facial (DCF) morphology. Population sample will be patients treated in the Maxillofacial Surgery department of "Hospital de Cruces". As inclusion criteria: ≥18 years-old, moderate-severe SAHS in supine position, multidisciplinary committee of sleep pathology evaluation for surgical indication, and written informed consents. As exclusion criteria: pregnant woman, SAHS of central origin, cranium-facial deformities that significantly modify normal UA, different surgery than MMA and inconclusive / incomplete tests. It is estimated ≥90% males; ≥90% 30-59 years-old; ≤10% extreme weights; 25% complementary surgeries; and sample size 40. Medical ethics code of the Declaration of Helsinki will be taken into account. To collect the pre- / postoperative data we will use, calibrated and standardized: polysomnography (PSG), computed tomography (CT), right face profile picture (RFP) and lateral teleradiography of the cranium (LTC). Furthermore, the Epworth scale and non-validated subjective self-perception test of facial aesthetics will be performed. Clinical outcomes will be evaluated from PSG using apnoea / hypopnoea index and pulse oximeter oxygen saturation, and from Epworth scale. UA morphology from CT, globally and by specific locations, through lengths, volumes, areas, dimensions, and other measurements. DCF aspects from RFP and LTC, by Ricketts cephalometric basic analysis and facial aesthetics test. Statistical, descriptive analysis of frequencies and comparative by pairs of quantitative data will be by t-Student or Wilcoxon test, after checking the variables normality with the Kolmogorov-Smirnov test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
March 4, 2020
CompletedFirst Posted
Study publicly available on registry
March 10, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedFebruary 10, 2021
February 1, 2021
11 months
March 4, 2020
February 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Upper-airway morphology: Vertical length
From computed-tomography examinations. Total, retropalatal compartment, retro-glossal compartment, hypopharynx compartment and summatory. Measured in mm.
Through study completion, an average of 1 year
Upper-airway morphology: volume
From computed-tomography examinations. Total, retropalatal compartment, retro-glossal compartment, hypopharynx compartment and summatory. Measured in mm\^3.
Through study completion, an average of 1 year
Upper-airway morphology: area
From computed-tomography examinations. Minimum, hard palate plane, parallel uvula tip plane, parallel epiglottis tip plane, parallel inferior edge of the hyoid bone plane. Measured in mm. Measured in mm\^2.
Through study completion, an average of 1 year
Upper-airway morphology: ellipticity
A formula: transversal dimension / anteroposterior dimension. Dimensions characteristics are: From computed-tomography examinations. Minimum, hard palate plane, parallel uvula tip plane, parallel epiglottis tip plane, parallel inferior edge of the hyoid bone plane. Measured in mm.
Through study completion, an average of 1 year
Upper-airway morphology: uniformity
A formula: minimum area / (hard palate area + uvula tip area + epiglottis tip area + hyoid bone area) Measured in units from 0 to 1.
Through study completion, an average of 1 year
Upper-airway morphology: prevertebral soft tissue length
From computed-tomography examinations. Measured in mm.
Through study completion, an average of 1 year
Upper-airway morphology: soft palate length
From computed-tomography examinations. Measured in mm.
Through study completion, an average of 1 year
Upper-airway morphology: position of the hyoid bone
From computed-tomography examinations. Measured in mm in the anteroposterior aspect and also the superoinferior aspect, this one is the same measure as vertical length.
Through study completion, an average of 1 year
Secondary Outcomes (22)
Clinical outcomes: Apnoea / hypopnoea index
Through study completion, an average of 1 year
Clinical outcomes: pulse oximeter oxygen saturation.
Through study completion, an average of 1 year
Clinical outcomes: daytime sleepiness
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: facial axis angle
Through study completion, an average of 1 year
Dental-cranium-facial morphology: Ricketts cephalometric basic analysis: facial depth
Through study completion, an average of 1 year
- +17 more secondary outcomes
Study Arms (2)
Preoperative (Pre-)
Moderate-severe obstructive sleep apnoea / hypopnoea patients, preoperative
Postoperative (Post-)
Moderate-severe obstructive sleep apnoea / hypopnoea patients, postoperative
Interventions
Maxilla: Lefort I osteotomy Mandible: Obwegeser-Dal-Pont osteotomy Movements: Advance and counterclockwise rotation
Eligibility Criteria
Adult patients treated in a single centre: Maxillofacial Surgery department, "Hospital de Cruces", Barakaldo, Spain Time period from 01/01/2012 to 01/31/2019.
You may qualify if:
- ≥18 years-old.
- Diagnosis by polysomnography of moderate-severe obstructive sleep apnoea / hypopnoea syndrome (SAHS) in supine position.
- Approval of the surgical indication by the multidisciplinary sleep committee of our hospital
You may not qualify if:
- Pregnant woman
- Central SAHS
- Medical-surgical history that significantly alter the normal upper-airway anatomy: trauma, tumour, major congenital craniofacial deformity
- Different orthognathic surgery than MMA
- Inconclusive / incomplete tests and data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital de Cruceslead
- University of the Basque Country (UPV/EHU)collaborator
- Biobizkaia Health Research Institutecollaborator
Study Sites (1)
Carlos Prol
Barakaldo, Bizkaia, 48903, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carlos Prol, Mr
Osakidetza
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Oral & Maxillofacial Consultant
Study Record Dates
First Submitted
March 4, 2020
First Posted
March 10, 2020
Study Start
February 4, 2019
Primary Completion
December 31, 2019
Study Completion
November 30, 2021
Last Updated
February 10, 2021
Record last verified: 2021-02